Google DeepMind unveiled AlphaGenome, a unified AI model predicting effects of DNA variants across molecular genomic properties with superior performance over existing tools. Meanwhile, Healx and SCI Ventures partnered to harness AI for accelerating drug discovery in spinal cord injury, targeting chronic neurotrauma. These advances highlight AI’s role in integrating vast omics data to enhance precision medicine and speed therapeutic development for complex diseases.